American Healthcare REIT, Inc. (AHR) AI Stock Analysis

• Market Cap: $6.03B
• Dividend Yield: 2.68%
• Average Volume (3M): 1.47M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.62
• Revenue Growth: 11.30%
• EPS Growth: N/A
• Country: US
• Employees: 114
• Sector: General
• Sector Strength: N/A
• Industry: REIT - Healthcare Facilities
• EPS (TTM): -0.04
• Shares Outstanding: 159,496,800
• 10 Day Avg. Volume: 905,407
• 30 Day Avg. Volume: 1,474,867
• PEG Ratio: -0.31
• Price to Book (P/B): 0.18
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 11.48
• Enterprise Value/Market Cap: 0.14
• Enterprise Value/Revenue: 0.10
• Enterprise Value/Gross Profit: 0.98
• Enterprise Value/Ebitda: 0.68
• 1Y Price Target: $40.30
• Price Target Upside: 7.90% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 10

• Rating: 68 Neutral
• Price Target: $39.00 ▲(4.42%Upside)

The overall stock score of 68 reflects the company's strong financial performance marked by revenue growth and improved operational efficiency, despite ongoing profitability challenges. Technical indicators support a positive outlook with strong momentum. Although the valuation is hampered by a negative P/E ratio, the attractive dividend yield and positive corporate events contribute to investor appeal.

Positive Factors

Acquisition Strategy

AHR's favorable cost of equity has led to lower leverage and provided visibility for the company to remain highly acquisitive.

Earnings Growth

The stock price is expected to react positively due to a solid earnings beat and one of the biggest guidance raises this quarter.

Market Positioning

AHR is uniquely positioned to outperform over the foreseeable future given its exposure to senior housing RIDEA assets, which are believed to carry some of the best fundamentals in real estate.

Negative Factors

Comparative Valuation

Shares of AHR currently trade at 19x 2026E FAD, below other RIDEA-exposed peers, suggesting the market may not fully value AHR’s organic revenue growth and reduced leverage.

Financial Projections

Lowering FFO Estimates due to recent property dispositions and equity offering.

Operational Challenges

The income statement published in the earnings press release is missing values for Loss from unconsolidated entities.

American Healthcare REIT, Inc. Business Overview & Revenue Model

Company Description

American Healthcare REIT, Inc. (AHR) is a real estate investment trust (REIT) focused on owning and managing a diverse portfolio of healthcare-related properties across the United States. The company primarily invests in medical office buildings, senior housing, skilled nursing facilities, hospitals, and other healthcare facilities. AHR aims to provide stable and growing income to its investors through strategic acquisitions and effective property management in the healthcare sector.

How the Company Makes Money

American Healthcare REIT, Inc. generates revenue primarily through leasing its healthcare properties to healthcare providers and operators. The company earns rental income from long-term leases, which are often structured with inflation escalators or rent increases over time. AHR also benefits from property appreciation and capital gains by strategically acquiring and disposing of assets within its portfolio. Additionally, the company may form joint ventures or partnerships with healthcare operators to enhance property management and operational efficiency, further contributing to its earnings.

American Healthcare REIT, Inc. Financial Statement Overview

Summary

American Healthcare REIT, Inc. demonstrates robust revenue growth and improved operational efficiency. Despite improvements in cash flow and debt reduction, the company struggles with maintaining profitability, as evidenced by recurring net losses. The balance sheet shows a strong equity position but indicates potential risks associated with asset leverage.

Income Statement

American Healthcare REIT, Inc. shows a strong revenue growth trajectory but suffers from negative net income, impacting profitability metrics. Gross profit margins have improved significantly over the years, indicating operational efficiency, yet net profit margins remain negative due to consistent net losses.

Balance Sheet

The company's balance sheet reflects stable equity growth and a substantial reduction in total debt, leading to a healthy debt-to-equity ratio of 0.0 in the latest fiscal year. However, the company's assets are heavily leveraged against equity, suggesting potential risk if asset values fluctuate.

Cash Flow

Cash flows have shown improvement with positive free cash flow growth and a strong operating cash flow to net income ratio. However, fluctuations in capital expenditures and financing activities indicate potential volatility in cash flow management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.11B	2.07B	1.86B	1.62B	1.27B	1.19B
Gross Profit	847.83M	416.77M	356.83M	335.97M	235.11M	195.39M
EBITDA	237.96M	315.48M	324.26M	233.76M	186.00M	206.71M
Net Income	-40.72M	-37.81M	-71.47M	-81.30M	-47.79M	2.16M
Balance Sheet
Total Assets	4.46B	4.49B	4.58B	4.79B	4.58B	3.23B
Cash, Cash Equivalents and Short-Term Investments	86.06M	76.70M	43.45M	65.05M	81.60M	152.19M
Total Debt	0.00	1.87B	3.02B	3.11B	2.65B	1.88B
Total Liabilities	2.16B	2.18B	3.12B	3.14B	2.75B	2.16B
Stockholders Equity	2.26B	2.26B	1.27B	1.40B	1.58B	866.11M
Cash Flow
Free Cash Flow	170.60M	84.15M	-1.26M	76.25M	-61.78M	90.85M
Operating Cash Flow	242.66M	176.09M	98.53M	147.77M	17.91M	219.16M
Investing Cash Flow	-36.29M	-8.73M	9.40M	-118.58M	-138.65M	-147.94M
Financing Cash Flow	-179.71M	-134.74M	-129.06M	-42.92M	94.11M	-8.81M

American Healthcare REIT, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 37.35
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AHR, the sentiment is Positive. The current price of 37.35 is above the 20-day moving average (MA) of 36.99, above the 50-day MA of 35.79, and above the 200-day MA of 30.00, indicating a bullish trend. The MACD of 0.65 indicates Positive momentum. The RSI at 57.07 is Neutral, neither overbought nor oversold. The STOCH value of 60.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AHR.

American Healthcare REIT, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CTRE	78 Outperform	$5.99B	34.06	7.02%	4.00%	43.27%	80.97%
SBRA	77 Outperform	$4.34B	30.84	5.15%	6.59%	7.81%	179.16%
NHI	75 Outperform	$3.32B	22.56	10.56%	5.06%	7.44%	4.23%
AHR	68 Neutral	$6.03B	―	-1.93%	2.68%	11.30%	―
HR	59 Neutral	$5.66B	―	-6.83%	7.69%	-7.26%	18.45%
Sector *	56 Neutral	$6.23B	21.98	-28.61%	4.90%	10.73%	-32.66%
MPW	48 Neutral	$2.60B	―	-28.86%	7.41%	19.56%	-12.73%

American Healthcare REIT, Inc. Corporate Events

American Healthcare REIT Holds Annual Stockholders Meeting

On June 25, 2025, American Healthcare REIT, Inc. held its Annual Meeting of Stockholders where four key proposals were voted upon. The stockholders elected nine directors for a one-year term, ratified Deloitte & Touche as the independent accounting firm for 2025, approved executive compensation for 2024 on an advisory basis, and approved the 2025 Manager Equity Plan. These decisions reflect the company’s ongoing governance and strategic planning efforts, potentially impacting its operational and financial management in the coming year.

The most recent analyst rating on (AHR) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.

American Healthcare REIT Announces Quarterly Distribution

On June 20, 2025, American Healthcare REIT, Inc. announced a quarterly distribution of $0.25 per share for the second quarter of 2025, payable on or about July 18, 2025, to shareholders of record as of June 30, 2025. This distribution reflects an annualized rate of $1.00 per share and underscores the company’s commitment to providing returns to its investors, potentially enhancing its attractiveness in the real estate investment sector.

The most recent analyst rating on (AHR) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.

American Healthcare REIT Reports Q1 2025 Financial Results

On May 8, 2025, American Healthcare REIT, Inc. announced its first quarter 2025 results, reporting a GAAP net loss attributable to controlling interest of $6.8 million and a GAAP net loss per diluted share of $0.04. Despite this, the company achieved a 15.1% growth in Same-Store Net Operating Income (NOI) compared to the previous year, driven by strong performance in its senior housing operating properties and integrated senior health campuses. The company also increased its full-year 2025 guidance, reflecting improved expectations for NOI growth and earnings, supported by successful capital markets activity and strategic asset transactions. The company remains focused on leveraging demand for long-term care and pursuing new growth opportunities.